The antibodies we create after we're infected with a virus or vaccinated against it can be very powerful. A virus typically spreads within our bodies by entering a cell and using it as a factory to create copies of itself, ...
Jun 10, 2021
0
3
Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent ...
Jun 2, 2021
0
6
The human papillomavirus (HPV) can cause cancer and many countries run national vaccination programs to minimize the risk. Studies involving researchers at German Cancer Research Center, Karolinska Institutet and Tampere ...
May 31, 2021
0
17
A study coordinated by Luís Graça, principal investigator at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) and Professor at the Faculty of Medicine of the University of Lisbon (FMUL) used lymph ...
May 28, 2021
0
55
The Pfizer and Moderna Covid vaccines should remain highly effective against two coronavirus variants first identified in India, according to new research carried out by US scientists.
May 17, 2021
0
168
The Lundquist Institute spinoff start-up company Vitalex Biosciences, founded by researcher Dr. Ashraf Ibrahim, is producing an antibody that stems the spread of mucormycosis, a deadly fungal infection with an overall mortality ...
May 17, 2021
0
3
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai. The fully ...
May 16, 2021
0
3
The most complete picture yet is shedding light on how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, ...
May 4, 2021
0
267
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials.
Apr 6, 2021
0
111
A new antibody that can mount a double attack on the SARS-CoV-2 virus by binding to two different sites on the spike protein is starting human trials, leading to hopes of an antibody therapy that can maintain its effectiveness ...
Mar 25, 2021
0
5
